Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone
Aug 4, 2026, 7:22:31 AM
3
min read
Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
Sep 17, 2025, 9:08:36 AM
3
min read
Intro to Allograft Tissue
Intro to Allograft Tissue
Jun 28, 2024, 9:58:09 AM
4
min read
April 25
AANS
April 25-28
Boston, MA
April 25
May 1
WPMA
May 1-3
Brookfield, WI
May 1
May 1
Rush Spine Forum
May 1-3
Scottsdale, AZ
May 1
May 1
GNS 2025
May 23-25
Sea Island, GA
May 1
May 1
ESTROT
May 30 - Jun 1
Leeds, UK
May 1
May 1
State of Spine
Jun 26-28
San Jose del Cabo, Mexico
May 1